Reactivity of human natural antibodies to endothelial cells from Galα(1,3)Gal-deficient pigs

Transplantation

Volumn 83, Issue 2, 2007, Pages 193-201

  Baumann, Bettina C ^a   Stussi, Georg ^a   Huggel, Katja ^a   Rieben, Robert ^b   Seebach, Jörg D ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Endothelial cells; Natural antibodies; Xenotransplantation

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN BINDING; ARTICLE; BLOOD DONOR; CELL ASSAY; CELL ISOLATION; CHROMIUM 51 RELEASE; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; LYMPHOBLASTOID CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT; XENOTRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DISACCHARIDES; ENDOTHELIAL CELLS; ERYTHROCYTES; HUMANS; SWINE;

EID: 33846590924     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000250478.00567.e5     Document Type: Article

References (41)

1. Cooper DK, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu Rev Med 2002; 53: 133.
2. Galili U. The alpha-gal epitope (Gal alpha 1-3Gal beta 1-4GlcNAc-R) in xenotransplantation. Biochimie 2001; 83: 557.
3. Cascalho M, Platt JL. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437.
4. Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480.
5. Schaapherder AF, Daha MR, te Bulte MT, et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57: 1376.
6. Seebach JD, Yamada K, McMorrow I, et al. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation 1996; 3: 188.
7. McMorrow IM, Comrack CA, Sachs DH, DerSimonian H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. Transplantation 1997; 64: 501.
8. Galili U, Anaraki F, Thall A, et al. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 1993; 82: 2485.
9. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1, 3-galactosyltransferase-deficient pigs. Science 2003; 299: 411.
10. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1, 3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 2004; 101: 7335.
11. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29.
12. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3- galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32.
13. Tseng YL, Kuwaki K, Dor FJ, et al. alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1493.
14. Chen G, Qian H, Starzl T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295.
15. Milland J, Christiansen D, Lazarus BD, et al. The Molecular Basis for Gal[alpha](1,3)Gal Expression in Animals with a Deletion of the [alpha]1,3Galactosyltransferase Gene. J Immunol 2006; 176: 2448.
16. Baumann BC, Forte P, Hawley RJ, et al. Lack of galactose-alpha-1, 3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J Immunol 2004; 172: 6460.
17. Baumann BC, Schneider MK, Lilienfeld BG, et al. Endothelial cells derived from pigs lacking Gala(1,3)Gal: no reduction of human leukocyte adhesion and NK cytotoxicity. Transplantation 2005; 79: 1067.
18. Buonomano R, Tinguely C, Rieben R, et al. Quantitation and characterization of anti-Galalpha1-3Gal antibodies in sera of 200 healthy persons. Xenotransplantation 1999; 6: 173.
19. McMorrow IM, Comrack CA, Nazarey PP, et al. Relationship between ABO blood group and levels of Gal alpha,3Galactose-reactive human immunoglobulin G. Transplantation 1997; 64: 546.
20. Oostingh GJ, Davies HF, Arch BN, et al. Potential implications of ABO blood group for vascular rejection in pig to human kidney xenotransplantation. Xenotransplantation 2003; 10: 278.
21. Seebach JD, Schneider MK, Comrack CA, et al. Immortalized bonemarrow derived pig endothelial cells. Xenotransplantation 2001; 8: 48.
22. Huang CA, Fuchimoto Y, Gleit ZL, et al. Posttransplantation lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: similarity to human PTLD and association with a porcine gammaherpesvirus. Blood 2001; 97: 1467.
23. Pins MR, Saidman SL, Cosimi AB, et al. Accelerated acute rejection of an apparent A2 renal allograft in an O recipient: report of a case with flow cytometric analysis. Transplantation 1997; 63: 984.
24. Stussi G, Huggel K, Lutz HU, et al. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol 2005; 130: 954.
25. Seebach JD, Comrack C, Germana S, et al. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997; 159: 3655.
26. Hasselaar P, Triplett DA, LaRue A, et al. Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA. J Rheumatol 1990; 17: 186.
27. Gerber B, Tinguely C, Bovin NV, et al. Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti-Galalpha1-3Gal antibodies from human serum. Xenotransplantation 2001; 8: 106.
28. Teranishi K, Manez R, Awwad M, Cooper DK. Anti-Gal alpha 1-3Gal IgM and IgG antibody levels in sera of humans and old world nonhuman primates. Xenotransplantation 2002; 9: 148.
29. Keusch JJ, Manzella SM, Nyame KA, et al. Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids. J Biol Chem 2000; 275: 25308.
30. Taylor SG, McKenzie IF, Sandrin MS. Characterization of the rat alpha(1,3)galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways. Glycobiology 2003; 13: 327.
31. Sharma A, Naziruddin B, Cui C, et al. Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation 2003; 75: 430.
32. Dor FJ, Tseng YL, Cheng J, et al. alpha1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies. Transplantation 2004; 78: 15.
33. Cooper DK. Xenoantigens and xenoantibodies. Xenotransplantation 1998; 5: 6.
34. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002; 9: 376.
35. Gollackner B, Goh SK, Qawi I, et al. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 2004; 77: 1735.
36. Lam TT, Hausen B, Boeke-Purkis K, et al. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914. Xenotransplantation 2004; 11: 517.
37. Brandl U, Michel S, Erhardt M, et al. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model. Xenotransplantation 2005; 12: 134.
38. Watier H, Guillaumin JM, Piller F, et al. Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells. Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity. Transplantation 1996; 62: 105.
39. Parker W, Lundberg-Swanson K, Holzknecht ZE, et al. Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies. Hum Immunol 1996; 45: 94.
40. Galili U, Ishida H, Tanabe K, Toma H. Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts. Transplantation 2002; 74: 1574.
41. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med 2001; 11: 325.